Chimera Investment (CIM) came out with quarterly earnings of $0.37 per share, beating the Zacks Consensus Estimate of $0.36 per share. This compares to earnings of $0.39 per share a year ago. These ...

Gilead Sciences (GILD) could open near nine-year highs after beating fourth-quarter earnings and revenue estimates ...

The company reported $261 million in revenue and adjusted earnings of $0.09 per share, slightly above analysts' consensus ...

CVS Health’s adjusted fourth-quarter profit handily beat Wall Street’s estimates, even as the drugstore chain and pharmacy benefits manager dealt with rising costs in its insurance division.

The company reported revenue of $219 million and earnings of $0.26 per share, surpassing the consensus estimates of $181 ...

Edwards Lifesciences Corporation EW reported fourth-quarter 2024 adjusted earnings per share (EPS) of 59 cents, which surpassed the Zacks Consensus Estimate by 7.3%. The figure increased 7.3% from the ...

U.S. electric and gas utility company NiSource on Wednesday raised its adjusted earnings forecast for 2025 and beat fourth-quarter profit estimates, benefiting from higher industrial electricity ...

Compass Minerals' Salt segment saw significant revenue decline due to lower tonnage sold. Read why CMP stock is a Buy for ...

Biogen expects Leqembi and new rare disease and depression treatments to help offset revenue lost from multiple sclerosis ...

Prospect Capital's portfolio continues to show weakness in a high interest rate environment. Read why I downgrade PSEC stock ...

Shares of CVS Health surged in premarket trading Wednesday after the health insurance and pharmacy giant reported better-than-expected fourth-quarter results.

Exelon forecast annual profit above Wall Street estimates on Wednesday, as the U.S. utility expects to benefit from higher ...